87
3
RAFI (Rural Advancement Foundation International). 1994. Conserving indigenous knowledge:
Integrating two systems of innovation. An independent study. New York: United Nations
Development Programme.
RAFI. 1995. Biopiracy Update: A Global Pandemic. RAFI Communique, September/October 1995.
Reid, W.V., S.A. Laird, C.A. Meyer, R. Gámez, A. Sittenfeld, D.H. Janzen, M.A. Gollin, and C. Juma.
1993. Biodiversity prospecting: Using genetic resources for sustainable development. Baltimore:
World Resources Institute.
Reyes, V. 1996. The value of sangre de drago. Seedling 13 (1): 16–21.
Richter, R.K., et al. Undated. Mutualism: An ethnomedical research collaboration between Shaman
Pharmaceuticals and the Institute of Traditional Medicine in Tanzania. Unpublished draft article.
San Fransisco: Shaman Pharmaceuticals.
Roe, E. 1991. Development narratives, or making the best of blueprint development. World
Development 19 (4): 287–300.
———. 1995. Except-Africa: Postscript to a special section on development narratives. World
Development 23 (6): 1065–1069.
———. 1999. Except-Africa. Remaking development, rethinking power. New Brunswick: Transaction
Publishers.
Shaman Pharmaceuticals. 1997a. Shaman Pharmaceuticals. 1996 annual report. San Francisco.
———. 1997b. Products in development & research focus. San Francisco: Shaman Pharmaceuticals.
Shiva, V. 1997. Biopiracy. The plunder of nature and knowledge. Boston: South End Press.
———. 2007. Comparative perspectives symposium: Bioprospecting/biopiracy: Bioprospecting as
sophisticated biopiracy. Journal of Women in Culture and Society 32 (2): 307–313.
Svarstad, H. 2000. Reciprocity, biopiracy, heroes, villains and victims. In Responding to bioprospecting. From biodiversity in the south to medicines in the north, ed. H. Svarstad and S.S. Dhillion.
Oslo: Spartacus.
———. 2002. Analysing conservation-environment discourses: The story of a biopiracy narrative.
Forum for Development Studies 29: 1.
———. 2003. Bioprospecting: Global discourses and local perceptions – Shaman Pharmaceuticals in
Tanzania. SUM dissertation and thesis 6/03, Center for Development and the Environment,
University in Oslo.
———. 2005. A global political ecology of bioprospecting. In Political ecology across spaces, scales
and social groups, ed. S. Paulson and L. Gezon. New Brunswick: Rutgers University Press.
Svarstad, H., H.C. Bugge, and S.S. Dhillion. 2000. From Norway to Novartis: Cyclosporin from
Tolypocladium inflatum in an open access bioprospecting regime. Biodiversity and Conservation
9: 1521–1541.
Svarstad, H., L.K. Petersen, D. Rothman, H. Siepel, and F. Wätzold. 2008. Discursive biases of the
environmental research framework DPSIR. Land Use Policy 25 (1): 116–125.
SynBioWatch. 2016. The 2016 Captain Hook Awards for Biopiracy – submit your nominations now!
http://www. synbiowatch. org/2016/11/the-2016-captain-hook-awards-for-biopiracy-submit-yournominations-now/. Visited 14 May 2020.
United Nations. 1992. Convention on biological diversity. Rio de Janeiro. http://www. cbd. int/convention/convention. shtml.
Weber, M. 1949. ‘Objectivity’ in social science and social policy. In The methodology of the social sciences, ed. E.A. Shils and H.A. Finch. Glencoe: The Free Press of Glencoe.
WWF Norway. 1998. Soppen fra Hardangervidda. Verdens Natur 2.
Wynberg, R., and S. Laird. 2007. Bioprospecting – Tracking the policy debate. Environment 49 (10):
20–32.
———. 2009. Bioprospecting, access and benefit sharing: Revisiting the ‘grand gargain’. In Indigenous
peoples, consent and benefit sharing: Lessons from the San-Hoodia case, ed. R. Wynberg,
D. Schroeder, and R. Chennells. Dordrecht: Springer.
Wynberg, R., D. Schroeder, and R. Chennells, eds. 2009. Indigenous peoples, consent and benefit sharing: Lessons from the San-Hoodia case. Dordrecht: Springer.
References
3
RAFI (Rural Advancement Foundation International). 1994. Conserving indigenous knowledge:
Integrating two systems of innovation. An independent study. New York: United Nations
Development Programme.
RAFI. 1995. Biopiracy Update: A Global Pandemic. RAFI Communique, September/October 1995.
Reid, W.V., S.A. Laird, C.A. Meyer, R. Gámez, A. Sittenfeld, D.H. Janzen, M.A. Gollin, and C. Juma.
1993. Biodiversity prospecting: Using genetic resources for sustainable development. Baltimore:
World Resources Institute.
Reyes, V. 1996. The value of sangre de drago. Seedling 13 (1): 16–21.
Richter, R.K., et al. Undated. Mutualism: An ethnomedical research collaboration between Shaman
Pharmaceuticals and the Institute of Traditional Medicine in Tanzania. Unpublished draft article.
San Fransisco: Shaman Pharmaceuticals.
Roe, E. 1991. Development narratives, or making the best of blueprint development. World
Development 19 (4): 287–300.
———. 1995. Except-Africa: Postscript to a special section on development narratives. World
Development 23 (6): 1065–1069.
———. 1999. Except-Africa. Remaking development, rethinking power. New Brunswick: Transaction
Publishers.
Shaman Pharmaceuticals. 1997a. Shaman Pharmaceuticals. 1996 annual report. San Francisco.
———. 1997b. Products in development & research focus. San Francisco: Shaman Pharmaceuticals.
Shiva, V. 1997. Biopiracy. The plunder of nature and knowledge. Boston: South End Press.
———. 2007. Comparative perspectives symposium: Bioprospecting/biopiracy: Bioprospecting as
sophisticated biopiracy. Journal of Women in Culture and Society 32 (2): 307–313.
Svarstad, H. 2000. Reciprocity, biopiracy, heroes, villains and victims. In Responding to bioprospecting. From biodiversity in the south to medicines in the north, ed. H. Svarstad and S.S. Dhillion.
Oslo: Spartacus.
———. 2002. Analysing conservation-environment discourses: The story of a biopiracy narrative.
Forum for Development Studies 29: 1.
———. 2003. Bioprospecting: Global discourses and local perceptions – Shaman Pharmaceuticals in
Tanzania. SUM dissertation and thesis 6/03, Center for Development and the Environment,
University in Oslo.
———. 2005. A global political ecology of bioprospecting. In Political ecology across spaces, scales
and social groups, ed. S. Paulson and L. Gezon. New Brunswick: Rutgers University Press.
Svarstad, H., H.C. Bugge, and S.S. Dhillion. 2000. From Norway to Novartis: Cyclosporin from
Tolypocladium inflatum in an open access bioprospecting regime. Biodiversity and Conservation
9: 1521–1541.
Svarstad, H., L.K. Petersen, D. Rothman, H. Siepel, and F. Wätzold. 2008. Discursive biases of the
environmental research framework DPSIR. Land Use Policy 25 (1): 116–125.
SynBioWatch. 2016. The 2016 Captain Hook Awards for Biopiracy – submit your nominations now!
http://www. synbiowatch. org/2016/11/the-2016-captain-hook-awards-for-biopiracy-submit-yournominations-now/. Visited 14 May 2020.
United Nations. 1992. Convention on biological diversity. Rio de Janeiro. http://www. cbd. int/convention/convention. shtml.
Weber, M. 1949. ‘Objectivity’ in social science and social policy. In The methodology of the social sciences, ed. E.A. Shils and H.A. Finch. Glencoe: The Free Press of Glencoe.
WWF Norway. 1998. Soppen fra Hardangervidda. Verdens Natur 2.
Wynberg, R., and S. Laird. 2007. Bioprospecting – Tracking the policy debate. Environment 49 (10):
20–32.
———. 2009. Bioprospecting, access and benefit sharing: Revisiting the ‘grand gargain’. In Indigenous
peoples, consent and benefit sharing: Lessons from the San-Hoodia case, ed. R. Wynberg,
D. Schroeder, and R. Chennells. Dordrecht: Springer.
Wynberg, R., D. Schroeder, and R. Chennells, eds. 2009. Indigenous peoples, consent and benefit sharing: Lessons from the San-Hoodia case. Dordrecht: Springer.
References